Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Keiko who wrote (8220)	2/24/1998 2:06:00 PM
From: AgAuUSA	Read Replies (1) \| Respond to of 14328

" The bigger hurdle , at least for some firms is simply cost. Saliva Diagnostics Systems SDS, a small firm based in Vancouver, WA, has three rapid tests it would like to launch in the United States. But without a backer, that will prove rough , says Paul Slowey, PhD, chief operating officer and vice president of SDS. " People want these kinds of tests very badly right now." says Slowey. That's why the new rapid HIV tests will eventually find their way not only into the the US market, but into home-test kits as well, Slowey adds..." It's simple...Consumers want to know! FWIW, I am hearing from nursing homes, schools, public health clinics and private practitioners. They cite the sore need for a simple, inexpensive, fast, convenient and disposable test for use in POC areas. I have been hearing this for many years. I believe the Trinity test fits the requirements of these users to a T. MGT: GO FOR IT!!!!